Indications and uses
• relieves occasional constipation (irregularity) • generally produces a bowel movement in 6-12 hours
• relieves occasional constipation (irregularity) • generally produces a bowel movement in 6-12 hours
• take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age and older 2 tablets once a day 4 tablets twice a day children 6 to under 12 years of age 1 tablet once a day 2 tablets twice a day children 2 to under 6 years of age 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
Sennosides 8.6 mg
Laxative
you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
age | starting dosage | maximum dosage |
adults and children 12 years of age and older | 2 tablets once a day | 4 tablets twice a day |
children 6 to under 12 years of age | 1 tablet once a day | 2 tablets twice a day |
children 2 to under 6 years of age | 1/2 tablet once a day | 1 tablet twice a day |
children under 2 years | ask a doctor | ask a doctor |
Calcium carbonate, croscarmellose sodium, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, propylene glycol, silicon dioxide, sodium sulfate, stearic acid, triacetin.
If you have any questions or comments,or to report an adverse event, please contact (800) 795-9775.
NDC 63187-683-00
PlusPHARMA
Relabeled by:
Proficient Rx LP
Thousand Oaks, CA 91320
Senna
Standardized Senna Concentrate
8.6 mg Sennosides Each
Natural Vegetable Laxative Ingredient
*Compare to Senokot®
Product color may vary slightly due to nature of ingredients.
*Plus Pharma is not affiliated with the owner of the registered trademark Senokot®.
100 TABLETS

| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51645-851-10 | EA - Each | 51645-851 | ec774260-08e4-4076-8a87-d96c3a929024 | 1 | 2021-11-09 |
| 51645-851-99 | EA - Each | 51645-851 | 8f93eb26-17ef-46d5-b2d2-63cd91fa3c7a | 1 | 2016-03-04 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63187-683 | 63187-683-30, 63187-683-60, 63187-683-90, 63187-683-00 |
| 51645-851 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CALCIUM CARBONATE | H0G9379FGK | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| SODIUM SULFATE | 0YPR65R21J | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TRIACETIN | XHX3C3X673 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 646ed418-3af6-4d87-bd6b-f95c2a5c733a | 9641cbbb-cf36-4310-b801-026298ae3536 | 2024-10-01 | Warnings | 9641cbbb-cf36-4310-b801-026298ae3536 |
Adverse event summaries are temporarily unavailable. Other product information remains available.